» Articles » PMID: 16928526

Accuracy of Surveillance Computed Tomography in Detecting Recurrent or New Primary Lung Cancer in Patients with Completely Resected Lung Cancer

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2006 Aug 25
PMID 16928526
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To determine the eventual outcome of abnormalities detected on surveillance computed tomography (CT) in patients with previously resected nonsmall-cell lung cancer (NSCLC), and to assess the accuracy of CT when used by the thoracic surgeon, and to determine the characteristics of abnormalities on CT that correlate with the development of recurrent NSCLC.

Methods: A cohort of patients who had abnormal postoperative CT scans of the chest and upper abdomen in 2002 were followed up into 2005. Abnormalities consisted of pulmonary nodules, pleural effusions, or adenopathy. Data collected included recurrence patterns, the availability of previous scans for comparison, the interval between initial resection and the abnormal CT, nodule size, growth, and multiplicity, as well as progression of pleural effusions or adenopathy.

Results: In all, 105 scans in 92 patients were read as abnormal in 2002 by the radiologist. After further investigation or follow-up, or both, for a mean of 3.2 years, 78% of patients who had recurrent NSCLC had their site of first recurrence inside the chest. The negative predictive value of CT when used by the thoracic surgeon was 99%; however, the positive predictive value was only 53%. Abnormalities that correlated with the diagnosis of recurrent cancer included pulmonary nodules that either grew or were larger than 1 cm and pleural effusions that developed after the first postoperative year.

Conclusions: Intrathoracic recurrent NSCLC was rarely missed by the surgeon utilizing surveillance CT, but a significant number of negative investigations were generated by its use. Characteristics of abnormal surveillance CT findings exist that correlate with the presence of malignancy.

Citing Articles

Association between imaging surveillance frequency and outcomes following surgical treatment of early-stage lung cancer.

Heiden B, Eaton D, Chang S, Yan Y, Schoen M, Thomas T J Natl Cancer Inst. 2022; 115(3):303-310.

PMID: 36442509 PMC: 9996218. DOI: 10.1093/jnci/djac208.


Assessment of Tissue Adequacy by EBUS in Conjunction with PET Scan and Operator's Experience.

Karim N, Ullah A, Pulliam S, Mostafa A, Aragaki A, Eubanks A Clin Pract. 2022; 12(6):942-949.

PMID: 36412678 PMC: 9680420. DOI: 10.3390/clinpract12060099.


Clinical Value of Surveillance F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy.

Lim C, Park S, Kim H, Choi Y, Kim J, Ahn Y Cancers (Basel). 2022; 14(3).

PMID: 35158900 PMC: 8833387. DOI: 10.3390/cancers14030632.


Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancer.

Keshava H, Tan K, Dycoco J, Huang J, Berkowitz A, Sumner D J Thorac Cardiovasc Surg. 2021; 163(5):1645-1653.e4.

PMID: 34922758 PMC: 9018489. DOI: 10.1016/j.jtcvs.2021.11.026.


Routine follow-up after surgical treatment of lung cancer: is chest CT useful?.

Morellato J, Guimaraes M, Medeiros M, Carneiro H, Oliveira A, Medici J J Bras Pneumol. 2021; 47(4):e20210025.

PMID: 34406226 PMC: 8352764. DOI: 10.36416/1806-3756/e20210025.